Thousands of chemical starting points for antimalarial lead identification

Malaria is a devastating infection caused by protozoa of the genus Plasmodium. Drug resistance is widespread, no new chemical class of antimalarials has been introduced into clinical practice since 1996 and there is a recent rise of parasite strains with reduced sensitivity to the newest drugs. We screened nearly 2 million compounds in GlaxoSmithKline’s chemical library for inhibitors of P. falciparum, of which 13,533 were confirmed to inhibit parasite growth by at least 80% at 2 µM concentration. More than 8,000 also showed potent activity against the multidrug resistant strain Dd2. Most (82%) compounds originate from internal company projects and are new to the malaria community. Analyses using historic assay data suggest several novel mechanisms of antimalarial action, such as inhibition of protein kinases and host–pathogen interaction related targets. Chemical structures and associated data are hereby made public to encourage additional drug lead identification efforts and further research into this disease.

[1]  Albert J. Leo,et al.  Quantitative Structure-Activity Relationships in Drug-Design , 1975 .

[2]  W. Trager,et al.  Human malaria parasites in continuous culture. , 1976, Science.

[3]  J. Haynes,et al.  Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique , 1979, Antimicrobial Agents and Chemotherapy.

[4]  M. Makler,et al.  Measurement of the lactate dehydrogenase activity of Plasmodium falciparum as an assessment of parasitemia. , 1993, The American journal of tropical medicine and hygiene.

[5]  J. Thompson,et al.  CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. , 1994, Nucleic acids research.

[6]  G. Bemis,et al.  The properties of known drugs. 1. Molecular frameworks. , 1996, Journal of medicinal chemistry.

[7]  Geoffrey I. McFadden,et al.  Plastid in human parasites , 1996, Nature.

[8]  Gapped BLAST and PSI-BLAST: A new , 1997 .

[9]  J. Palmer,et al.  A Plastid of Probable Green Algal Origin in Apicomplexan Parasites , 1997, Science.

[10]  Thomas D. Y. Chung,et al.  A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays , 1999, Journal of biomolecular screening.

[11]  K. Kirk,et al.  Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum , 2000, Nature.

[12]  T. Hunter,et al.  The Protein Kinase Complement of the Human Genome , 2002, Science.

[13]  Hugo Kubinyi,et al.  Quantitative Structure–Activity Relationships in Drug Design , 2002 .

[14]  Patricia De la Vega,et al.  Discovery of Gene Function by Expression Profiling of the Malaria Parasite Life Cycle , 2003, Science.

[15]  J. Derisi,et al.  The Transcriptome of the Intraerythrocytic Developmental Cycle of Plasmodium falciparum , 2003, PLoS biology.

[16]  Yufeng Wang,et al.  Data-mining approaches reveal hidden families of proteases in the genome of malaria parasite. , 2003, Genome Research.

[17]  Pauline Ward,et al.  Protein kinases of the human malaria parasite Plasmodium falciparum: the kinome of a divergent eukaryote , 2004, BMC Genomics.

[18]  David A. Fidock,et al.  Antimalarial drug discovery: efficacy models for compound screening , 2004, Nature Reviews Drug Discovery.

[19]  N Srinivasan,et al.  A genomic perspective of protein kinases in Plasmodium falciparum , 2004, Proteins.

[20]  Andrew M Davis,et al.  Components of successful lead generation. , 2005, Current topics in medicinal chemistry.

[21]  Weltgesundheitsorganisation.  World malaria report , 2005 .

[22]  T. Ramya,et al.  Inhibitors of Nonhousekeeping Functions of the Apicoplast Defy Delayed Death in Plasmodium falciparum , 2006, Antimicrobial Agents and Chemotherapy.

[23]  P. Bernardi,et al.  High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening , 2006, Archives of Toxicology.

[24]  G. McFadden,et al.  The effects of anti-bacterials on the malaria parasite Plasmodium falciparum. , 2007, Molecular and biochemical parasitology.

[25]  D. Pompliano,et al.  Drugs for bad bugs: confronting the challenges of antibacterial discovery , 2007, Nature Reviews Drug Discovery.

[26]  Daniel H. Huson,et al.  Dendroscope: An interactive viewer for large phylogenetic trees , 2007, BMC Bioinformatics.

[27]  Didier Leroy,et al.  Drugging the Plasmodium kinome: the benefits of academia-industry synergy. , 2008, Trends in pharmacological sciences.

[28]  Ruili Huang,et al.  Compound Cytotoxicity Profiling Using Quantitative High-Throughput Screening , 2007, Environmental health perspectives.

[29]  D. Fidock,et al.  In vitro evaluations of antimalarial drugs and their relevance to clinical outcomes. , 2008, International journal for parasitology.

[30]  B. Malnic,et al.  Genome-Wide Detection of Serpentine Receptor-Like Proteins in Malaria Parasites , 2008, PloS one.

[31]  Mindy I. Davis,et al.  A quantitative analysis of kinase inhibitor selectivity , 2008, Nature Biotechnology.

[32]  Bruce Russell,et al.  The pathophysiology of vivax malaria. , 2009, Trends in parasitology.

[33]  X. Su,et al.  Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum , 2009, Nature chemical biology.

[34]  R. Durand,et al.  Plasmodium falciparum Drug Resistance in Madagascar: Facing the Spread of Unusual pfdhfr and pfmdr-1 Haplotypes and the Decrease of Dihydroartemisinin Susceptibility , 2009, Antimicrobial Agents and Chemotherapy.

[35]  Stephane Proux,et al.  Changes in the Treatment Responses to Artesunate-Mefloquine on the Northwestern Border of Thailand during 13 Years of Continuous Deployment , 2009, PloS one.

[36]  E. Ashley,et al.  Varying efficacy of artesunate+amodiaquine and artesunate+sulphadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in the Democratic Republic of Congo: a report of two in-vivo studies , 2009, Malaria Journal.

[37]  Eileen Kraemer,et al.  PlasmoDB: a functional genomic database for malaria parasites , 2008, Nucleic Acids Res..

[38]  Daylight Theory Manual , 2011 .